Coronary or peripheral bypasses are the most frequently performed vascular operations. Although one million patients per year and around the world, undergo this intervention, its failure rate reaches 50%, because of poor ...
Jun 10, 2016
0
2
Cornell researchers have discovered potent cancer-killing proteins that can travel by white blood cells to kill tumors in the bloodstream of mice with metastatic prostate cancer. The breakthrough study will be published Feb. ...
Jan 12, 2016
0
33
Resveratrol and quercetin, two polyphenols that have been widely studied for their health properties, may soon become the basis of an important new advance in cancer treatment, primarily by improving the efficacy and potential ...
Jul 16, 2015
0
36
Researchers at the University of North Carolina at Chapel Hill have used exosomes—tiny bubbles of protein and fat produced naturally by cells—to bypass the body's defenses and deliver a potent antioxidant directly to ...
May 4, 2015
0
147
There are about 48,000 corneal transplants done each year in the U.S., compared to approximately 16,000 kidney transplants and 2,100 heart transplants. Out of the 48,000 corneal transplants done, 10 percent of them end up ...
Mar 9, 2015
0
7
Manchester scientists have found that gentle heating of targeted nano-sized drug parcels more effectively in deliver them to tumour cells – resulting in an improvement in survival rates.
Feb 11, 2015
0
5
Enara Herran, a researcher at the UPV/EHU's Department of Pharmacy and Pharmaceutical Technology, is working to improve the way Alzheimer's and Parkinson's treatments are administered. And it is a fact that, as Herran herself ...
Oct 20, 2014
0
0
The millions of people worldwide who suffer from the painful bladder disease known as interstitial cystitis (IC) may soon have a better, long-term treatment option, thanks to a controlled-release, implantable device invented ...
Oct 16, 2014
0
2
University of Mississippi School of Pharmacy researchers are studying an improved method for delivering drugs that treat pain and inflammation.
Oct 1, 2014
0
0
Scientists from the Institute for Biomedical Research (IRB Barcelona) have carried out successful in vitro tests using wasp venom to kill tumour cells. The next step will be to test its efficacy in mouse models.
Aug 5, 2014
0
0
